HeartFlow Stock After Institutional Moves: Buy or Not?
When an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
Explore Which Indices Move This Week and the key drivers behind recent changes. The section offers concise observations to help readers interpret market dynamics.
26,181 articlesWhen an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
Texas is attracting corporate headquarters, talent and capital at a pace unseen in years, redefining where investors ...
A prominent contrarian investor has revealed a bold, long-term bet on Microsoft, using December 2028 LEAP calls to ca...
The Magnificent Seven have long led the market, but their valuations have cooled. Explore the three biggest bargain p...
Prediction markets pricing pennies on a Bitcoin 150K scenario sound far-fetched—until you unpack how odds, liquidity,...
Ripple unveils a broad expansion in Brazil, layering cross-border payments and digital asset custody for regulated in...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
A large fund sold a substantial stake in Kennametal, igniting questions about the stock's trajectory. This article br...
A private equity veteran, famed for saving Arby’s, now champions a $2.7 billion bid for Pizza Hut. The deal splits be...
A top executive recently moved a sizable block of Impinj stock. This article unpacks why insider sales happen, how to...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
Three high-variance names—Moderna, Trade Desk, and MicroStrategy—reversed declines to rally in early March, signaling...